Examination of the effectiveness and safety of multidisciplinary therapy with docetaxel for high-risk prostate cancer
Phase 1
- Conditions
- prostate cancer
- Registration Number
- JPRN-UMIN000023145
- Lead Sponsor
- Juntendo University Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- Male
- Target Recruitment
- 100
Inclusion Criteria
Not provided
Exclusion Criteria
1.Males under the age of 20. 2. Refuses to give informed consent. 3. Refuses or is unable to have pelvic MRI or CT scan. 4. Without criteria for administration of docetaxel. 5. Deemed higher risk of administration of docetaxel by urologists or other physicians.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method biochemical recurrence-free survival (PSA)
- Secondary Outcome Measures
Name Time Method overall survival, safety of radiation therapy or surgery after administration of docetaxel